We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.7B
AUM Growth
-$3.96B
Cap. Flow
-$1.66B
Cap. Flow %
-13.11%
Top 10 Hldgs %
14.02%
Holding
2,200
New
84
Increased
771
Reduced
1,166
Closed
158
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVZ icon
726
Invesco
IVZ
$13.9B
$3.14M 0.02%
194,772
-87,547
-31% -$1.66M
ESAB icon
727
ESAB
ESAB
$5.71B
$3.14M 0.02%
+71,750
New +$3.46M
OLED icon
728
Universal Display
OLED
$4.19B
$3.12M 0.02%
30,879
-1,211
-4% -$156K
SRPT icon
729
Sarepta Therapeutics
SRPT
$1.77B
$3.11M 0.02%
41,512
+22
+0.1% +$1.62K
BNTX icon
730
BioNTech
BNTX
$23.5B
$3.1M 0.02%
20,798
-3,473
-14% -$531K
WAT icon
731
Waters Corp
WAT
$39.9B
$3.1M 0.02%
9,371
-8,548
-48% -$2.71M
EMB icon
732
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
$3.09M 0.02%
36,259
+1,560
+4% +$141K
MAN icon
733
ManpowerGroup
MAN
$2.63B
$3.06M 0.02%
40,102
+2,597
+7% +$227K
SGFY
734
DELISTED
Signify Health, Inc.
SGFY
$3.06M 0.02%
221,986
-7,000
-3% -$98.6K
ETG
735
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.85B
$3.06M 0.02%
189,954
-11,431
-6% -$202K
PHK
736
PIMCO High Income Fund
PHK
$880M
$3.05M 0.02%
590,474
-51,883
-8% -$290K
SSRM icon
737
SSR Mining
SSRM
$6.48B
$3.05M 0.02%
182,783
+32,622
+22% +$673K
IRWD icon
738
Ironwood Pharmaceuticals
IRWD
$711M
$3.05M 0.02%
264,676
+166,184
+169% +$1.96M
FHB icon
739
First Hawaiian
FHB
$3.35B
$3.04M 0.02%
134,063
-1,139
-0.8% -$28.6K
LUMN icon
740
Lumen
LUMN
$6.44B
$3M 0.02%
274,853
-184,739
-40% -$2.07M
PAAS icon
741
Pan American Silver
PAAS
$21.6B
$3M 0.02%
152,296
+21,797
+17% +$522K
SLQT icon
742
SelectQuote
SLQT
$121M
$2.98M 0.02%
1,201,881
-194
-0% -$497
HIW icon
743
Highwoods Properties
HIW
$3.47B
$2.97M 0.02%
86,966
+5,268
+6% +$208K
HIX
744
Western Asset High Income Fund II
HIX
$355M
$2.97M 0.02%
602,796
+109,973
+22% +$585K
SEE
745
DELISTED
Sealed Air
SEE
$2.97M 0.02%
51,379
-758
-1% -$47.8K
GNRC icon
746
Generac Holdings
GNRC
$12.5B
$2.96M 0.02%
14,061
-376
-3% -$92.5K
EXAS
747
DELISTED
Exact Sciences
EXAS
$2.95M 0.02%
74,899
+10,256
+16% +$548K
NBH
748
Neuberger Municipal Fund Inc
NBH
$304M
$2.94M 0.02%
262,499
+20,844
+9% +$244K
AGI icon
749
Alamos Gold
AGI
$13.9B
$2.93M 0.02%
417,589
+83,027
+25% +$646K
STT icon
750
State Street
STT
$50.7B
$2.93M 0.02%
47,571
-9,793
-17% -$693K

Similar funds

Guggenheim Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Guggenheim Capital held 2,200 positions worth $12.7B, down 24% from $16.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Guggenheim Capital withdrew a net $1.66B in Q2 2022, closing 158 positions and reducing 1,166 holdings. Its most notable exit was BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in ESAB worth $3.14M.

  • Guggenheim Capital's largest Q2 2022 buy was ESAB: 71,750 shares worth $3.14M.
  • Guggenheim Capital added most to Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q2 2022, an estimated $25.1M increase.
  • Guggenheim Capital's biggest Q2 2022 reduction was Apple, cutting an estimated $68.5M.
  • Guggenheim Capital fully exited BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC in Q2 2022, selling an estimated $13.1M.
  • Guggenheim Capital's ten largest holdings make up 14% of its $12.7B portfolio in Q2 2022.
  • Guggenheim Capital opened 84 new positions and closed 158 in Q2 2022.
  • Guggenheim Capital's portfolio value fell 24% quarter-over-quarter to $12.7B.

Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.